Literature DB >> 18558200

Avoiding misdiagnosing neuroblastoma as Wilms tumor.

Paxton V Dickson1, Thomas L Sims, Christian J Streck, M Beth McCarville, Victor M Santana, Lisa M McGregor, Wayne L Furman, Andrew M Davidoff.   

Abstract

PURPOSE: Although occasionally difficult, distinguishing abdominal neuroblastoma (NBL) from Wilms tumor (WT) at presentation is important, as surgical management differs significantly. We reviewed our 20-year experience (1987-2006) treating patients with NBL, focusing on those with an initial diagnosis of WT, to determine presenting features that would have suggested the correct preoperative diagnosis.
METHODS: Retrospective case cohort study reviewing charts and imaging of patients with NBL initially diagnosed clinically with WT. Preoperative symptoms, laboratory studies, and imaging were evaluated. Similar variables were assessed in the 20 patients with WT most recently treated at our institution.
RESULTS: Nine patients with NBL were identified as those who had an exploratory laparotomy with a preoperative diagnosis of WT; 8 underwent nephrectomy at exploration. Children with NBL had symptoms such as fever and weight loss at presentation (67%) more often than patients with WT (20%). Preoperative computed tomography demonstrated intratumoral calcifications, vascular encasement, or both in 78% of patients with NBL but were never seen in WT patients. Of interest, preoperative urinary catecholamines were elevated in 5 patients ultimately diagnosed with NBL.
CONCLUSION: Although NBL can be mistaken for WT at presentation, the presence of constitutional symptoms, or intratumoral calcification or vascular encasement on preoperative imaging should heighten suspicion for NBL. In addition, laboratory evaluation, including urinary catecholamines, should be completed before surgery when the etiology of an abdominal tumor is uncertain.

Entities:  

Mesh:

Year:  2008        PMID: 18558200      PMCID: PMC3214966          DOI: 10.1016/j.jpedsurg.2008.02.047

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  With advances in medical imaging can the radiologist reliably diagnose Wilms' tumours?

Authors:  D J Scott; W H Wallace; G M Hendry
Journal:  Clin Radiol       Date:  1999-05       Impact factor: 2.350

Review 2.  Pediatric solid malignancies: neuroblastoma and Wilms' tumor.

Authors:  Sunghoon Kim; Dai H Chung
Journal:  Surg Clin North Am       Date:  2006-04       Impact factor: 2.741

3.  Calcification in primary and metastatic Wilms' tumor.

Authors:  R A Kaufman; J F Holt; K P Heidelberger
Journal:  AJR Am J Roentgenol       Date:  1978-04       Impact factor: 3.959

4.  Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.

Authors:  Volker Strenger; Reinhold Kerbl; Hans Jürgen Dornbusch; Ruth Ladenstein; Peter F Ambros; Inge M Ambros; Christian Urban
Journal:  Pediatr Blood Cancer       Date:  2007-05       Impact factor: 3.167

Review 5.  The diagnosis and management of Wilms' tumor.

Authors:  D M Green
Journal:  Pediatr Clin North Am       Date:  1985-06       Impact factor: 3.278

6.  The risk of nephrectomy during local control in abdominal neuroblastoma.

Authors:  R C Shamberger; E I Smith; V V Joshi; P V Rao; F A Hayes; L C Bowman; R P Castleberry
Journal:  J Pediatr Surg       Date:  1998-02       Impact factor: 2.545

Review 7.  Neuroblastoma update.

Authors:  Marion C W Henry; David B Tashjian; Christopher K Breuer
Journal:  Curr Opin Oncol       Date:  2005-01       Impact factor: 3.645

Review 8.  Neuroblastoma: biological insights into a clinical enigma.

Authors:  Garrett M Brodeur
Journal:  Nat Rev Cancer       Date:  2003-03       Impact factor: 60.716

Review 9.  Advances in the diagnosis and treatment of neuroblastoma.

Authors:  Joanna L Weinstein; Howard M Katzenstein; Susan L Cohn
Journal:  Oncologist       Date:  2003

10.  Distinguishing neuroblastoma from Wilms tumor by computed tomography.

Authors:  G S Peretz; A H Lam
Journal:  J Comput Assist Tomogr       Date:  1985 Sep-Oct       Impact factor: 1.826

  10 in total
  7 in total

Review 1.  Recent Trends in the Quantification of Biogenic Amines in Biofluids as Biomarkers of Various Disorders: A Review.

Authors:  Alina Plenis; Ilona Olędzka; Piotr Kowalski; Natalia Miękus; Tomasz Bączek
Journal:  J Clin Med       Date:  2019-05-09       Impact factor: 4.241

2.  Fine-needle aspiration cytopathology in the diagnosis of Wilms tumor.

Authors:  I Fernández-Pineda; R Cabello; J A García-Cantón; S Pérez-Bertolez; I Tuduri; G Ramírez; C Márquez; J C de Agustín
Journal:  Clin Transl Oncol       Date:  2011-11       Impact factor: 3.405

3.  Clear cell sarcoma of the kidney with calcification and a novel chromosomal abnormality: a case report.

Authors:  Masaya Kato; Yuya Sato; Keitaro Fukushima; Mayuko Okuya; Hidemitsu Kurosawa; Shigeko Kuwashima; Koichi Honma; Kentaro Okamoto; Takashi Tsuchioka; Osamu Arisaka
Journal:  Diagn Pathol       Date:  2015-07-17       Impact factor: 2.644

4.  Case report: value of gene expression profiling in the diagnosis of atypical neuroblastoma.

Authors:  Anne C Harttrampf; Qingrong Chen; Eva Jüttner; Julia Geiger; Gordon Vansant; Javed Khan; Udo Kontny
Journal:  BMC Res Notes       Date:  2017-08-17

5.  Synchronous Bilateral Wilms Tumor: Five-Year Single-Center Experience with Assessment of Quality of Life.

Authors:  Hinglaj Saha; Dipak Ghosh; Somak Kumar Biswas; Prafulla Kumar Mishra; Kaushik Saha; Uttara Chatterjee
Journal:  J Indian Assoc Pediatr Surg       Date:  2019 Jan-Mar

6.  Primary renal neuroblastoma mimicking Wilms' tumor.

Authors:  Vedat Akçaer; Tuba Eren; Ebru Taştekin
Journal:  Balkan Med J       Date:  2021-03       Impact factor: 2.021

7.  Diffusion-weighted MRI and intravoxel incoherent motion model for diagnosis of pediatric solid abdominal tumors.

Authors:  Emma M Meeus; Niloufar Zarinabad; Karen A Manias; Jan Novak; Heather E L Rose; Hamid Dehghani; Katharine Foster; Bruce Morland; Andrew C Peet
Journal:  J Magn Reson Imaging       Date:  2017-11-21       Impact factor: 4.813

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.